120 related articles for article (PubMed ID: 38017611)
1. Preventive effect of culture supernatant of epithelial-like peritoneal mesothelial cells on peritoneal fibrosis.
Takahashi K; Tsuji K; Nakanoh H; Fukushima K; Kitamura S; Wada J
Perit Dial Int; 2024 May; 44(3):211-215. PubMed ID: 38017611
[TBL] [Abstract][Full Text] [Related]
2. The selection of peritoneal mesothelial cells is important for cell therapy to prevent peritoneal fibrosis.
Kitamura S; Horimoto N; Tsuji K; Inoue A; Takiue K; Sugiyama H; Makino H
Tissue Eng Part A; 2014 Feb; 20(3-4):529-39. PubMed ID: 24007428
[TBL] [Abstract][Full Text] [Related]
3. A protective role of nintedanib in peritoneal fibrosis through H19-EZH2-KLF2 axis via impeding mesothelial-to-mesenchymal transition.
Zhong W; Fu J; Liao J; Ouyang S; Yin W; Liang Y; Liu K
Int Urol Nephrol; 2024 Jun; 56(6):1987-1999. PubMed ID: 38097887
[TBL] [Abstract][Full Text] [Related]
4. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
[TBL] [Abstract][Full Text] [Related]
5. The role of macrophage-derived Exosomes in reversing peritoneal fibrosis: Insights from Astragaloside IV.
Shan Y; Yu M; Dai H; Zhu X; Wang F; You Y; Cao H; Sheng L; Zhao J; Tang L; Shi J; Sheng M
Phytomedicine; 2024 Jul; 129():155683. PubMed ID: 38701543
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of STAT3 by S3I-201 suppress peritoneal fibroblast phenotype conversion and alleviate peritoneal fibrosis.
Song Q; Li H; Yan H; Yu Z; Li Z; Yuan J; Jiang N; Ni Z; Gu L; Fang W
J Cell Mol Med; 2024 May; 28(10):e18381. PubMed ID: 38780509
[TBL] [Abstract][Full Text] [Related]
7. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel.
Saed GM; Kruger M; Diamond MP
Wound Repair Regen; 2004; 12(5):557-64. PubMed ID: 15453838
[TBL] [Abstract][Full Text] [Related]
8. Selective therapeutic efficacy of tyrosine kinase inhibitor sorafenib on the restoration of methylglyoxal-induced peritoneal fibrosis.
Wei YS; Wu CH; Lin SL; Tsai SY; Chen YT; Tsai PS
Biomed Pharmacother; 2024 Jul; 176():116905. PubMed ID: 38865848
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of epimorphin in a peritoneal fibrosis mouse model.
Yamada M; Hirai Y; Inoue D; Komatsu S; Uchida T; Kojima T; Tomiyasu T; Yoshikawa N; Oda T
Perit Dial Int; 2022 Sep; 42(5):522-529. PubMed ID: 34641723
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
11. The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells.
Lee SH; Kang HY; Kim KS; Nam BY; Paeng J; Kim S; Li JJ; Park JT; Kim DK; Han SH; Yoo TH; Kang SW
Lab Invest; 2012 Dec; 92(12):1698-711. PubMed ID: 23007133
[TBL] [Abstract][Full Text] [Related]
12. Diltiazem suppresses collagen synthesis and IL-1beta-induced TGF-beta1 production on human peritoneal mesothelial cells.
Fang CC; Yen CJ; Chen YM; Chu TS; Lin MT; Yang JY; Tsai TJ
Nephrol Dial Transplant; 2006 May; 21(5):1340-7. PubMed ID: 16421162
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1beta stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells.
Yang WS; Kim BS; Lee SK; Park JS; Kim SB
Perit Dial Int; 1999; 19(3):211-20. PubMed ID: 10433157
[TBL] [Abstract][Full Text] [Related]
14. Methylglyoxal induces peritoneal thickening by mesenchymal-like mesothelial cells in rats.
Hirahara I; Ishibashi Y; Kaname S; Kusano E; Fujita T
Nephrol Dial Transplant; 2009 Feb; 24(2):437-47. PubMed ID: 18790810
[TBL] [Abstract][Full Text] [Related]
15. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
16. Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Zhao J; Shi J; Shan Y; Yu M; Zhu X; Zhu Y; Liu L; Sheng M
Cell Mol Biol Lett; 2020; 25():33. PubMed ID: 32514269
[TBL] [Abstract][Full Text] [Related]
17. Curcumin ameliorates peritoneal fibrosis via inhibition of transforming growth factor-activated kinase 1 (TAK1) pathway in a rat model of peritoneal dialysis.
Zhao JL; Zhang T; Shao X; Zhu JJ; Guo MZ
BMC Complement Altern Med; 2019 Oct; 19(1):280. PubMed ID: 31647008
[TBL] [Abstract][Full Text] [Related]
18. The Selective Angiotensin II Type 2 Receptor Agonist Compound 21 Reduces Abdominal Adhesions in Mice.
Boudreau C; LeVatte T; Jones C; Gareau A; Legere S; Bezuhly M
J Surg Res; 2020 Dec; 256():231-242. PubMed ID: 32711180
[TBL] [Abstract][Full Text] [Related]
19. N-methylpiperazine-diepoxyovatodiolide ameliorates peritoneal fibrosis via suppressing TGF-β/Smad and JAK/STAT signaling pathway.
Mo M; Zeng Y; Zeng Y; Li S; He X; Chen X; Luo Q; Liu M; Luo C; Dou X; Peng F; Long H
Chem Biol Interact; 2023 Sep; 382():110589. PubMed ID: 37268199
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum.
Liu J; Jiang CM; Feng Y; Zhu W; Jin B; Xia YY; Zhang QY; Xu PF; Zhang M
Am J Transl Res; 2019; 11(3):1473-1485. PubMed ID: 30972175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
